Aeon Closes €8.2 Million Seed Funding Round Led By Concentric With Support From Investors

Aeon, a Zurich-based AI preventive health platform, recently raised €8.2 million ($9.41 million) in seed funding led by Concentric, with support from Calm/Storm Ventures, GoHub, Kadmos, EWOR, and angel Daniel Gutenberg. The funds will be used for expansion across Switzerland, Germany, and the UK, as well as to forge partnerships with insurers and employers and enhance its clinical network, including the opening of more than 10 new locations.

Summary of transaction details:

• Deal Type: Seed
• Transaction Amount: $9,410,000
• Key Investors: Concentric, Calm/Storm Ventures, GoHub, Kadmos, EWOR, Daniel Gutenberg

Aeon is led by CEO Tim Seithe and CPO Samuel Frey and employs a multi-modal AI platform to integrate MRI scans, genetic testing, and blood testing for early detection and personalized risk prediction of over 500 health conditions. The funding will facilitate strategic growth and broaden its clinical presence in key European markets.